ILNews

Federal courts rule against overtime in pharmaceutical cases

Back to TopCommentsE-mailPrintBookmark and Share

In a pair of decisions, the U.S. Supreme Court and the 7th Circuit Court of Appeals examined different exemption provisions to overtime requirements of the Fair Labor Standards Act but reached the same conclusion: Pharmaceutical sales representatives are not entitled to overtime pay.

The Supreme Court considered the outside salesman exemption in Christopher, et al. v. SmithKline Beecham Corp., 11-204, while the 7th Circuit reviewed the administrative exemption in Susan Schaefer-LaRose v. Eli Lilly & Co., 10-3855. Both courts sided with the employers, finding that although pharmaceutical “detailers,” as they are called in the drug-making industry, worked under heavy regulations and constraints, they did meet the overtime exemption requirements outlined in the FLSA.

guevara Guevara

Attorneys familiar with the two rulings point to broader implications that the cases hold, which could guide future decisions on wage-and-hour lawsuits as well as the behaviors of federal agencies.

In addition, the decisions come at a time when lawsuits filed under the FLSA are increasing. These types of cases have been growing: 1,961 cases were filed in the reporting year that ended March 2001, according to a report in Law360. The total hit 7,006 new cases filed during the reporting year that concluded March 2011 and rose again to 7,064 in the reporting year that finished March 31, 2012.

Eli Lilly & Co.

The 7th Circuit combined the Eli Lilly case with two others involving Illinois-based Abbott Laboratories. In these cases, the plaintiffs claimed they were misclassified as exempt and were due overtime pay. The defendants argued the employees were not entitled to overtime under both the administrative exemption and the outside sales exemption.

Since the Supreme Court was already looking at the outside sales provision, the 7th Circuit concentrated on the administrative exemption. Under this section of the FLSA, the administrative exemption applies to employees who do office or non-manual work directly related to the management or general operations of the company and who exercise discretion and independent judgment in matters of significance.

Ellen Boshkoff, partner at Faegre Baker Daniels LLP, was the lead counsel for Lilly. James O’Brien III, counsel at Seeger Weiss, was the lead counsel for Susan Schaefer-LaRose.

The plaintiff in the case had worked for Lilly from 1988 to 2006 and was frustrated by the long hours that often necessitated working on weekends and holidays, O’Brien said. She had to travel a great deal and was required to be in the field calling on physicians from 8 a.m. to 5 p.m. which meant she had to use her evening hours to complete the paperwork.

Seeger Weiss sent letters to 777 former and current sales representatives at Lilly, and 388 joined the Schaefer-LaRose case.

These plaintiffs maintained they did not meet the standard for exercising discretion and independent judgment because they had to perform their jobs according to precise regulations set forth by the U.S. Food and Drug Administration and by their employer.

In its opinion, the 7th Circuit reserved the District Court’s ruling in Abbott and upheld the ruling of the Southern District of Indiana in the Lilly case. The 7th Circuit found that although the sales personnel must deliver the pharmaceutical companies’ messages with precision, they are not “simple mouthpieces, reciting scripts.” They are given extensive education and training, work under minimal supervision, and must tailor their messages to respond to the circumstances.

The 7th Circuit’s ruling marks the ninth consecutive decision, stretching over 63 years, in which the court found the employee at issue was not entitled to overtime under the administrative exemption, according to O’Brien. Not since its 1949 opinion in McComb v. Robert W. Hunt Co., 172 F.2d 751 (7th Cir. 1949), has the court held that an employee did not perform administratively exempt work, he said.

Boshkoff believes the ruling from the 7th Circuit, as well as from the Supreme Court, will provide guidance not just in cases involving pharmaceutical sales representatives but for anyone seeking clarification of the administrative exemption. It is an important case, she said, that people will use when applying the administrative exemption to employees in such positions as human resources, marketing, accounting and procurement.

SmithKline Beecham Corp.

Focusing on the outside sales exemption, the Supreme Court rejected the plaintiffs’ argument that their job duties do not meet the standard of selling. Pharmaceuticals detailers are barred from directly selling drugs by federal law, so they solicit nonbinding commitments from physicians to prescribe the product.

boshkoff Boshkoff

The court held that what the detailers were doing did meet FLSA’s broad definition of “outside salesman” which allows a “nonbinding commitment” to qualify as a sale. They were functioning as sales representatives, even though they were not actually selling pharmaceuticals, in part because they received a commission based on the number of prescriptions written.

A key element to the ruling is the Supreme Court’s decision not to give deference to the U.S. Department of Labor’s interpretation of the outside salesman exemption. The court faulted the agency for changing its reasoning over what constitutes a sale in the briefs it filed with the lower courts and held the interpretation “lacks the hallmarks of thorough consideration.” In addition, it noted that the department first announced its position in a series of amicus briefs which did not provide the opportunity for public comment.

Greg Guevara, partner in the labor and employment group at Bose McKinney & Evans LLP, sees this decision as reminding the labor department to make regulations through the established due process instead of in the courts.

“The broader implications are that the Supreme Court essentially said to the Department of Labor that if they want to take a position regarding the Fair Labor Standards Act, they need to do this through the formalized rulemaking process rather than through litigation,” Guevara said. “I think the potential ramification is if there is going to be a change in the way that the white collar exemptions are interpreted, it is more likely the Department of Labor is going to pursue the change through the rulemaking process.”

The federal agency filed briefs on behalf of the plaintiffs in the cases, but the 7th Circuit did not consider the department’s amicus brief because it determined the regulations regarding the administrative exemption were unambiguous.

On the other hand, the Supreme Court noted that while deference is usually given to an agency’s interpretation of its own “ambiguous regulation,” giving deference in the SmithKline Beecham case to the department’s interpretation of the outside sales exemption would bring an “‘unfair surprise’ against which this Court has long warned.”

The court highlighted that the pharmaceutical industry has treated its detailers as exempt outside salesmen for decades and the Department of Labor never brought any enforcement action. In turn, the “only plausible explanation” for the department’s inaction is that it accepted the practice. •
 

ADVERTISEMENT

  • NAXIDEX DEXAMETHASONE WARNING
    I had eye surgery and in the post-op pack was MAXIDEX(dexamethasone) drops by ALCON LABS TWO days later I was BLIND Use Google and enter MAXIDEX LOSS OF VISION to verify or call 800-757-9195

Post a comment to this story

COMMENTS POLICY
We reserve the right to remove any post that we feel is obscene, profane, vulgar, racist, sexually explicit, abusive, or hateful.
 
You are legally responsible for what you post and your anonymity is not guaranteed.
 
Posts that insult, defame, threaten, harass or abuse other readers or people mentioned in Indiana Lawyer editorial content are also subject to removal. Please respect the privacy of individuals and refrain from posting personal information.
 
No solicitations, spamming or advertisements are allowed. Readers may post links to other informational websites that are relevant to the topic at hand, but please do not link to objectionable material.
 
We may remove messages that are unrelated to the topic, encourage illegal activity, use all capital letters or are unreadable.
 

Messages that are flagged by readers as objectionable will be reviewed and may or may not be removed. Please do not flag a post simply because you disagree with it.

Sponsored by
ADVERTISEMENT
Subscribe to Indiana Lawyer
  1. I'm glad that attorney Carl Hayes, who represented the BMV in this case, is able to say that his client "is pleased to have resolved the issue". Everyone makes mistakes, even bureaucratic behemoths like Indiana's BMV. So to some extent we need to be forgiving of such mistakes. But when those mistakes are going to cost Indiana taxpayers millions of dollars to rectify (because neither plaintiff's counsel nor Mr. Hayes gave freely of their services, and the BMV, being a state-funded agency, relies on taxpayer dollars to pay these attorneys their fees), the agency doesn't have a right to feel "pleased to have resolved the issue". One is left wondering why the BMV feels so pleased with this resolution? The magnitude of the agency's overcharges might suggest to some that, perhaps, these errors were more than mere oversight. Could this be why the agency is so "pleased" with this resolution? Will Indiana motorists ever be assured that the culture of incompetence (if not worse) that the BMV seems to have fostered is no longer the status quo? Or will even more "overcharges" and lawsuits result? It's fairly obvious who is really "pleased to have resolved the issue", and it's not Indiana's taxpayers who are on the hook for the legal fees generated in these cases.

  2. We are a Finance Industry Company professionals with over 15 Years Experience and a focus on providing Bank Guarantee and Standby Letter of Credit from some of the World Top 25 Prime Banks primarily from Barclays, Deutsche Bank, HSBC,Credit Suisse e.t.c. FEATURES: Amounts from $1 million to 5 Billion+ Euro’s or US Dollars Great Attorney Trust Account Protection Delivered via MT760, MT799 and MT103 Swift with Full Bank Responsibility Brokers Always Protected Purchase Instrument of BG/SBLC : 32%+2% Min Face Value cut = EUR/USD 1M-5B Lease Instrument of BG/SBLC : 4%+2% Min Face Value cut = EUR/USD 1M-5B Interested Agents/Brokers, Investors and Individual proposing international project funding should contact us for directives.We will be glad to share our working procedures with you upon request. We Facilitate Bank instruments SBLC for Lease and Purchase. Whether you are a new startup, medium or large establishment that needs a financial solution to fund/get your project off the ground or business looking for extra capital to expand your operation,our company renders credible and trusted bank guarantee provider who are willing to fund and give financing solutions that suits your specific business needs. We help you secure and issue sblc and bank guarantee for your trade, projects and investment from top AA rated world Banks like HSBC, Barclays, Dutch Ing Bank, Llyods e.t.c because that’s the best and safest strategy for our clients.e.t.c DESCRIPTION OF INSTRUMENTS 1. Instrument: Funds backed Bank Guarantee(BG) ICC-600 2. Currency : USD/EURO 3. Age of Issue: Fresh Cut 4. Term: One year and One day 5. Contract Amount: United State Dollars/Euros (Buyers Face Value) 6. Price : Buy:32%+1, Lease: 4%+2 7. Subsequent tranches: To be mutually agreed between both parties 8. Issuing Bank: Top RATED world banks like HSBC, Barclays, ING Dutch Bank, Llyods e.t.c 9. Delivery Term: Pre advise MT199 or MT799 first. Followed By SWIFT MT760 10. Payment Term: MT799 & Settlement via MT103 11. Hard Copy: By Bank Bonded Courier Interested Agents,Brokers, Investors and Individual proposing international project funding should contact us for directives.We will be glad to share our working procedures with you upon request. Name:Richardson McAnthony Contact Mail : intertekfinance@gmail.com

  3. Affordable Loan Offer (ericloanfinance@hotmail.com) NEED A LOAN?Sometime i really wanna help those in a financial problems.i was wondering why some people talks about inability to get a loan from a bank/company. have you guys ever try Eric Benson lending service.it cost dollars to loan from their company. my aunty from USA,just got a home loan from Eric Benson Lending banking card service.and they gave her a loan of 8,000,000 USD. they give out loan from 100,000 USD - 100,000,000 USD. try it yourself and testimony. have a great day as you try.Kiss & Hug. Contact E-mail: ericloanfinance@hotmail.com

  4. From the article's fourth paragraph: "Her work underscores the blurry lines in Russia between the government and businesses . . ." Obviously, the author of this piece doesn't pay much attention to the "blurry lines" between government and businesses that exist in the United States. And I'm not talking only about Trump's alleged conflicts of interest. When lobbyists for major industries (pharmaceutical, petroleum, insurance, etc) have greater access to this country's elected representatives than do everyday individuals (i.e., voters), then I would say that the lines between government and business in the United States are just as blurry, if not more so, than in Russia.

  5. For some strange reason this story, like many on this ezine that question the powerful, seems to have been released in two formats. Prior format here: http://www.theindianalawyer.com/nominees-selected-for-us-attorney-in-indiana/PARAMS/article/44263 That observed, I must note that it is quite refreshing that denizens of the great unwashed (like me) can be allowed to openly question powerful elitists at ICE MILLER who are on the public dole like Selby. Kudos to those at this ezine who understand that they cannot be mere lapdogs to the powerful and corrupt, lest freedom bleed out. If you wonder why the Senator resisted Selby, consider reading the comments here for a theory: http://www.theindianalawyer.com/nominees-selected-for-us-attorney-in-indiana/PARAMS/article/44263

ADVERTISEMENT